Today's Low
₹ 262.15
Today's High
₹ 271.05
52 Weeks Low
₹ 191.55
52 Weeks High
₹ 347.10
Lower
₹ 262.50
Upper
₹ 320.80
Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, dermatology, ophthalmology, neurology, rheumatology, and inflammatory diseases. It is also involved in the integrated discovery, development, and manufacturing services for small and large molecules, antibody-drug conjugates, and oligonucleotides. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 12,334.0 | 8,382.3 | 7,548.2 | 5,325.0 | 4,888.5 | 4,148.6 | 4,047.7 | 3,970.9 | 2,562.6 | 2,638.8 | 2,240.0 | 1,999.7 | 1,807.2 | 1,477.2 | 1,121.9 | 978.7 | 590.9 | 408.8 | 493.8 | 566.8 | 146.1 | 101.4 |
Total Non-Current Assets | 39,407.8 | 11,718.4 | 10,614.2 | 8,750.8 | 6,979.2 | 5,647.7 | 5,149.0 | 4,415.7 | 3,812.8 | 3,111.8 | 2,176.1 | 1,937.5 | 1,779.4 | 1,460.6 | 1,422.7 | 1,101.1 | 983.5 | 878.6 | 596.1 | 219.4 | 143.9 | 117.5 |
Total Assets | 51,741.8 | 20,100.7 | 18,214.6 | 14,075.8 | 11,867.7 | 9,796.3 | 9,196.7 | 8,386.6 | 6,375.4 | 5,750.6 | 4,416.1 | 3,937.2 | 3,586.6 | 2,937.8 | 2,544.6 | 2,079.8 | 1,574.4 | 1,287.4 | 1,089.9 | 786.2 | 290.0 | 218.9 |
Total Current Liabilities | 8,510.7 | 3,828.0 | 4,169.7 | 4,008.0 | 3,038.5 | 2,141.3 | 1,678.3 | 1,665.7 | 1,554.7 | 1,379.6 | 989.9 | 1,015.8 | 1,060.6 | 581.7 | 438.5 | 301.4 | 275.0 | 261.3 | 248.7 | 140.9 | 73.0 | 53.8 |
Total Non-Current Liabilities | 20,742.3 | 6,802.7 | 5,496.9 | 2,684.7 | 2,122.3 | 2,006.5 | 2,304.6 | 2,421.3 | 1,377.9 | 1,262.0 | 666.3 | 645.2 | 455.5 | 564.4 | 570.5 | 301.6 | 231.6 | 134.8 | 99.8 | 82.4 | 82.9 | 77.6 |
Shareholder's Funds | 17,866.9 | 8,432.5 | 7,626.9 | 6,705.8 | 6,098.0 | 5,180.8 | 4,837.7 | 4,033.8 | 3,270.6 | 3,026.7 | 2,694.6 | 2,272.4 | 2,032.8 | 1,757.9 | 1,510.7 | 1,484.2 | 1,068.6 | 888.1 | 740.5 | 562.9 | 134.2 | 87.5 |
Total Liabilities | 51,741.8 | 20,100.7 | 18,214.6 | 14,075.8 | 11,867.7 | 9,796.3 | 9,196.7 | 8,386.6 | 6,375.4 | 5,750.6 | 4,416.1 | 3,937.2 | 3,586.6 | 2,937.8 | 2,544.6 | 2,079.8 | 1,574.4 | 1,287.4 | 1,089.9 | 786.2 | 290.0 | 218.9 |
The Industry Price to BV stands at 6.03, vs the Price to BV of 1.59, which results in a Negative aspect.
The Industry Quick Ratio stands at 1.60, vs the Quick Ratio of 0.97, which results in a Negative aspect.
The Industry Current Ratio stands at 2.31, vs the Current Ratio of 1.33, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.22, vs the Debt to Equity Ratio of 0.40, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Income | 11,174.2 | 8,184.0 | 7,143.1 | 6,300.5 | 5,514.4 | 4,123.4 | 3,891.1 | 3,347.4 | 3,089.8 | 2,877.3 | 2,485.3 | 2,332.1 | 2,784.4 | 2,367.8 | 1,608.7 | 1,053.8 | 985.7 | 789.2 | 712.6 | 540.6 | 282.0 |
Total Expenditure | 9,054.7 | 6,691.4 | 5,841.0 | 5,043.5 | 4,390.6 | 3,294.3 | 2,911.6 | 2,584.3 | 2,394.0 | 2,190.2 | 1,946.3 | 1,809.3 | 2,213.4 | 1,896.3 | 1,285.3 | 757.7 | 712.0 | 562.0 | 491.9 | 369.8 | 210.5 |
Operating Profit(Excl OI) | 2,887.6 | 2,182.9 | 1,907.3 | 1,764.5 | 1,538.1 | 1,035.3 | 1,136.6 | 847.0 | 748.9 | 743.0 | 595.7 | 586.6 | 628.1 | 508.5 | 387.9 | 335.0 | 287.4 | 234.8 | 240.2 | 180.5 | 74.1 |
Add: Other Income | 768.1 | 690.3 | 605.2 | 507.5 | 414.3 | 206.2 | 157.1 | 83.9 | 53.1 | 55.9 | 56.7 | 63.8 | 57.1 | 37.0 | 64.6 | 38.9 | 13.7 | 7.7 | 19.5 | 9.6 | 2.5 |
Operating Profit | 2,887.6 | 2,182.9 | 1,907.3 | 1,764.5 | 1,538.1 | 1,035.3 | 1,136.6 | 847.0 | 748.9 | 743.0 | 595.7 | 586.6 | 628.1 | 508.5 | 387.9 | 335.0 | 287.4 | 234.8 | 240.2 | 180.5 | 74.1 |
Less: Interest | 419.0 | 67.6 | 57.7 | 64.9 | 70.9 | 61.5 | 26.0 | 29.3 | 8.9 | 1.7 | 8.1 | 12.4 | 24.3 | 16.9 | 17.7 | 10.2 | 9.9 | 2.6 | 2.7 | 2.5 | 5.0 |
PBDT | 2,468.6 | 2,115.3 | 1,849.6 | 1,699.6 | 1,467.2 | 973.8 | 1,110.6 | 817.7 | 740.0 | 741.3 | 587.6 | 574.2 | 603.8 | 491.6 | 370.3 | 324.8 | 277.6 | 232.2 | 237.5 | 178.0 | 69.1 |
Less: Depreciation Amortization | 1,113.1 | 814.2 | 715.1 | 552.2 | 447.8 | 385.1 | 277.2 | 248.7 | 221.0 | 203.6 | 179.3 | 175.8 | 156.7 | 140.1 | 110.3 | 93.9 | 66.6 | 29.7 | 22.3 | 16.3 | 13.7 |
PBT & Exceptional Items | 1,355.5 | 1,301.1 | 1,134.5 | 1,147.4 | 1,019.4 | 588.7 | 833.4 | 569.0 | 519.0 | 537.7 | 408.3 | 398.4 | 447.1 | 351.5 | 260.0 | 230.9 | 211.0 | 202.6 | 215.1 | 161.7 | 55.3 |
Less: Exceptional Income Expenses | -291.4 | -111.1 | 12.6 | 67.5 | 194.6 | 0.0 | 0.0 | 160.6 | 105.1 | 0.0 | 201.9 | 0.0 | 0.0 | 0.0 | -147.2 | 239.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | 897.1 | 983.1 | 1,067.7 | 1,214.9 | 1,214.9 | 610.0 | 849.7 | 751.3 | 624.1 | 537.7 | 610.2 | 398.4 | 447.1 | 351.5 | 112.8 | 470.3 | 211.0 | 202.6 | 215.1 | 161.7 | 55.3 |
Less: Taxation | 254.1 | 211.5 | 221.5 | 315.1 | 212.3 | 156.9 | 161.6 | 142.2 | 95.7 | 106.9 | 97.5 | 55.9 | 72.1 | 48.7 | 11.8 | 12.9 | 16.9 | 30.6 | 18.6 | 23.0 | 11.8 |
Profit After Tax | 643.0 | 771.6 | 846.2 | 899.8 | 1,002.6 | 453.1 | 688.1 | 609.1 | 528.4 | 430.8 | 512.7 | 342.5 | 375.0 | 302.8 | 101.0 | 457.4 | 194.1 | 172.0 | 196.5 | 138.6 | 43.5 |
Earnings Per Share | 0.4 | 0.5 | 0.6 | 0.6 | 0.8 | 0.3 | 0.5 | 0.5 | 0.4 | 0.3 | 0.4 | 0.3 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
The Industry Dividend Yield stands at 0.60, vs the Dividend Yield of 0.57, which results in a Negative aspect.
The Industry PAT Growth stands at 32.18, vs the PAT Growth of -10.25, which results in a Negative aspect.
The Industry PAT Margin stands at 9.77, vs the PAT Margin of 14.28, which results in a Positive aspect.
The Industry PE Ratio stands at 42.56, vs the PE Ratio of 26.18, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Profit Before Tax | 897.1 | 983.1 | 1,067.7 | 1,186.0 | 1,214.9 | 610.0 | 849.7 | 751.3 | 624.1 | 537.7 | 610.2 | 395.2 | 447.1 | 351.5 | 104.4 | 538.7 | 211.0 | 202.5 | 215.1 | 161.7 | 55.3 | 26.1 |
Tax Paid | -228.6 | -262.0 | -193.8 | -344.1 | -291.5 | -197.1 | -203.0 | -246.5 | -133.4 | -148.7 | -94.0 | -73.9 | -81.3 | -32.8 | -16.9 | -24.3 | -13.2 | -22.7 | -12.0 | -19.7 | -9.8 | -3.3 |
Adjustment | 1,685.0 | 1,245.0 | 709.6 | 606.3 | 260.3 | 355.7 | 204.4 | 42.0 | 74.0 | 134.0 | 147.3 | 144.8 | 163.5 | 159.7 | 135.9 | -213.8 | 82.2 | 27.6 | 12.7 | 17.8 | 22.1 | 12.5 |
Changes In Working Capital | 897.1 | 983.1 | 1,067.7 | 1,186.0 | 1,214.9 | 610.0 | 849.7 | 751.3 | 624.1 | 537.7 | 610.2 | 395.2 | 447.1 | 351.5 | 104.4 | 538.7 | 211.0 | 202.5 | 215.1 | 161.7 | 55.3 | 26.1 |
Cash Flow after changes in Working Capital | 2,081.1 | 1,438.6 | 1,353.5 | 1,627.2 | 1,446.1 | 859.2 | 843.0 | 617.1 | 344.1 | 709.4 | 565.2 | 638.0 | 879.8 | 476.6 | 112.0 | 342.2 | 168.0 | 103.6 | 184.4 | 148.4 | 59.2 | 18.5 |
Cash Flow from Operating Activities | 1,852.5 | 1,176.6 | 1,159.7 | 1,283.1 | 1,154.6 | 662.1 | 640.0 | 370.6 | 210.7 | 560.7 | 471.2 | 564.1 | 798.5 | 443.8 | 95.1 | 317.9 | 154.8 | 80.9 | 172.4 | 128.6 | 49.4 | 15.2 |
Cash Flow from Investing Activities | -14,281.8 | -1,699.1 | -3,624.7 | -1,558.9 | -713.8 | -684.0 | -498.5 | -1,141.7 | -508.7 | -938.1 | -375.8 | -359.5 | -314.5 | -226.1 | -232.2 | -340.1 | -191.2 | -88.8 | -485.2 | -108.1 | -45.3 | -41.3 |
Cash Flow from Financing Activities | 13,048.7 | 242.1 | 2,564.0 | 387.6 | -241.7 | -239.7 | -177.5 | 1,067.6 | 186.2 | 426.0 | -8.6 | -186.3 | -274.6 | -85.2 | 136.9 | 23.2 | 43.1 | 4.7 | -1.8 | 294.3 | -3.3 | 24.0 |
Net Cash Inflow / Outflow | 619.4 | -280.4 | 99.0 | 111.8 | 199.1 | -261.6 | -36.0 | 296.5 | -111.8 | 48.6 | 86.8 | 18.3 | 209.4 | 132.5 | -0.2 | 1.0 | 6.7 | -3.2 | -314.5 | 314.9 | 0.8 | -2.1 |
Opening Cash & Cash Equivalents | 653.7 | 897.0 | 824.7 | 659.3 | 449.0 | 710.2 | 757.5 | 457.5 | 557.0 | 474.0 | 369.0 | 359.0 | 139.9 | 11.8 | 9.6 | 8.6 | 2.0 | 3.4 | 317.5 | 2.6 | 1.9 | 0.0 |
Closing Cash & Cash Equivalent | 1,294.8 | 653.7 | 897.0 | 824.7 | 659.3 | 449.0 | 710.2 | 757.5 | 462.6 | 557.0 | 474.0 | 369.0 | 359.0 | 143.1 | 11.8 | 9.6 | 8.6 | 2.0 | 3.4 | 317.5 | 2.6 | 1.9 |
The Industry PCF RATIO stands at 24.29, vs the PCF RATIO of 25.31, which results in a Positive aspect.
The Industry PFCF Ratio stands at 25.12, vs the PFCF Ratio of -59.08, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 39,537.0 | 34,623.0 | 34,226.0 | 37,739.0 | 29,411.0 | 23,197.0 | 21,395.0 | 24,088.0 | 21,742.0 | 18,404.0 | 17,606.0 | 18,387.0 | 18,510.0 | 17,448.0 | 16,713.0 | 15,810.0 |
Total Income | 45,192.0 | 36,202.0 | 35,161.0 | 39,288.0 | 30,197.0 | 23,842.0 | 22,174.0 | 24,761.0 | 22,225.0 | 19,453.0 | 18,078.0 | 20,441.0 | 18,789.0 | 17,603.0 | 16,896.0 | 16,441.0 |
Total Expenditure | 30,269.0 | 27,207.0 | 27,082.0 | 27,766.0 | 22,968.0 | 18,490.0 | 17,401.0 | 18,169.0 | 16,860.0 | 13,946.0 | 13,713.0 | 14,029.0 | 14,515.0 | 13,534.0 | 12,580.0 | 12,624.0 |
PBIDT (Excl OI) | 9,268.0 | 7,416.0 | 7,144.0 | 9,973.0 | 6,443.0 | 4,707.0 | 3,994.0 | 5,919.0 | 4,882.0 | 4,458.0 | 3,893.0 | 4,358.0 | 3,995.0 | 3,914.0 | 4,133.0 | 3,186.0 |
Other Income | 5,655.0 | 1,579.0 | 935.0 | 1,549.0 | 786.0 | 645.0 | 779.0 | 673.0 | 483.0 | 1,049.0 | 472.0 | 2,054.0 | 279.0 | 155.0 | 183.0 | 631.0 |
Operating Profit | 14,923.0 | 8,995.0 | 8,079.0 | 11,522.0 | 7,229.0 | 5,352.0 | 4,773.0 | 6,592.0 | 5,365.0 | 5,507.0 | 4,365.0 | 6,412.0 | 4,274.0 | 4,069.0 | 4,316.0 | 3,817.0 |
Interest | 2,667.0 | 2,477.0 | 2,330.0 | 2,488.0 | 1,203.0 | 300.0 | 199.0 | 105.0 | 147.0 | 225.0 | 199.0 | 339.0 | 48.0 | 65.0 | 125.0 | 168.0 |
Exceptional Items | 212.0 | -240.0 | 0.0 | -30.0 | -2,714.0 | -170.0 | 0.0 | -410.0 | 0.0 | -701.0 | 0.0 | 126.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 12,468.0 | 6,278.0 | 5,749.0 | 9,004.0 | 3,312.0 | 4,882.0 | 4,574.0 | 6,077.0 | 5,218.0 | 4,581.0 | 4,166.0 | 6,199.0 | 4,226.0 | 4,004.0 | 4,191.0 | 3,649.0 |
Depreciation | 4,145.0 | 3,893.0 | 3,580.0 | 3,637.0 | 3,011.0 | 2,308.0 | 2,175.0 | 2,122.0 | 2,057.0 | 2,015.0 | 1,948.0 | 1,843.0 | 1,863.0 | 1,777.0 | 1,668.0 | 1,524.0 |
Profit Before Tax | 8,323.0 | 2,385.0 | 2,169.0 | 5,367.0 | 301.0 | 2,574.0 | 2,399.0 | 3,955.0 | 3,161.0 | 2,566.0 | 2,218.0 | 4,356.0 | 2,363.0 | 2,227.0 | 2,523.0 | 2,125.0 |
Tax | 549.0 | 416.0 | 348.0 | 821.0 | -48.0 | 1,473.0 | 295.0 | 586.0 | 493.0 | 463.0 | 573.0 | 694.0 | 489.0 | 223.0 | 809.0 | 450.0 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 7,774.0 | 1,969.0 | 1,821.0 | 4,546.0 | 349.0 | 1,101.0 | 2,104.0 | 3,369.0 | 2,668.0 | 2,103.0 | 1,645.0 | 3,662.0 | 1,874.0 | 2,004.0 | 1,714.0 | 1,675.0 |
Net Profit | 7,774.0 | 1,969.0 | 1,821.0 | 4,546.0 | 349.0 | 1,101.0 | 2,104.0 | 3,369.0 | 2,668.0 | 2,103.0 | 1,645.0 | 3,659.0 | 1,874.0 | 2,004.0 | 1,714.0 | 1,675.0 |
ADDITIONAL INFOS: | ||||||||||||||||
Equity Capital | 6,003.0 | 6,003.0 | 6,003.0 | 6,003.0 | 6,003.0 | 6,003.0 | 6,003.0 | 6,003.0 | 6,003.0 | 6,003.0 | 6,003.0 | 6,000.0 | 6,000.0 | 6,000.0 | 6,000.0 | 6,000.0 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 5.5 | 1.1 | 0.9 | 2.6 | -0.4 | 0.4 | 1.2 | 2.0 | 1.6 | 1.2 | 0.7 | 2.1 | 1.4 | 1.5 | 1.3 | 1.0 |
Operating Profit Margin | 37.7 | 26.0 | 23.6 | 30.5 | 24.6 | 23.1 | 22.3 | 27.4 | 24.7 | 29.9 | 24.8 | 34.9 | 23.1 | 23.3 | 25.8 | 24.1 |
Net Profit Margin | 19.7 | 5.7 | 5.3 | 12.0 | 1.2 | 4.7 | 9.8 | 14.0 | 12.3 | 11.4 | 9.3 | 19.9 | 10.1 | 11.5 | 10.3 | 10.6 |
The Industry Mcap Growth stands at 19.69, vs the Mcap Growth of -11.42, which results in a Negative aspect.
The Industry Net Sales Growth stands at 11.07, vs the Net Sales Growth of 14.26, which results in a Positive aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 272.65 | 278.63 | 264.68 |
R3 | 270.22 | 269.90 | 263.16 |
R2 | 267.78 | 267.63 | 262.66 |
R1 | 264.72 | 264.40 | 262.15 |
Pivot | 262.28 | 262.13 | 262.28 |
S1 | 259.22 | 258.90 | 261.15 |
S2 | 256.78 | 256.63 | 260.64 |
S3 | 253.72 | 253.40 | 260.14 |
S4 | 250.65 | 245.63 | 258.63 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
49.58
Neutral
RSI
50.51
Neutral
ROC
-0.24
Bearish
UltimateOscillator
39.34
Neutral
Williams Indicator
-57.50
Neutral
CCI Indicator
15.38
Neutral
MACD
-2,727.14
Bearish
Stochastic Indicator
38.01
Neutral
ATR
9.31
Low Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
07-07-2023 | 1.50 | 30 | Final |
30-06-2022 | 0.50 | 10 | Final |
Date Of Conduct | Board Meeting Details |
---|---|
16-05-2024 | Audited Results & Final Dividend |
08-02-2024 | Quarterly Results |
10-11-2023 | Quarterly Results |
10-08-2023 | Quarterly Results |
23-05-2023 | Final Dividend & Audited Results & A.G.M. |
26-04-2023 | Inter alia, to consider the issue of Secured, Redeemable, Non-Convertible Debentures on private placement basis, investment in securities to be issued by Biocon Biologics Limited and provision of guarantees/put options, amongst other matters. |
14-02-2023 | Quarterly Results |
14-11-2022 | Quarterly Results |
27-07-2022 | Quarterly Results |
28-04-2022 | Audited Results & Dividend |
20-01-2022 | Quarterly Results |
21-10-2021 | Quarterly Results |
22-07-2021 | Quarterly Results |
28-04-2021 | Final Dividend & Audited Results |